In MF, topical resiquimod has been associated with increased activation of NK and CD8+ T-cells within treated lesions, alongside histologic regression and, notably, regression of distant, untreated lesions—suggestive of an abscopal effect. This evidence concerns the gene CD8A and mycosis fungoides.